DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
S••••• S••••
Healthcare & Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Also written as: S••••• S•••• 2025
Principal held
at least $3.6M
sum of BDC pieces, a lower bound
Fair value
$3.9M
102c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
2
1 on the latest quarter
Facilities
5
1 equity pieces beside them
Next maturity
Mar 25, 2031
no dated debt inside 24 months
On the tape since
Dec 31, 2024
latest Jun 30, 2026
Events
4
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $3.6M | 102c | SOFR+475 bp | Mar 25, 2031 | 2 |
| first lien revolver first lien | at least $69,088 | n/a | SOFR+475 bp | Mar 25, 2031 | 1 |
| first lien delayed draw term loan first lien | unknown | n/a | SOFR+475 bp | Mar 25, 2031 | 1 |
| delayed draw term loan lien unstated exited Jun 30, 2025 | unknown | n/a | SOFR+475 bp | Mar 25, 2033 | 1 |
| revolver lien unstated exited Sep 30, 2025 | unknown | n/a | SOFR+475 bp | Mar 25, 2031 | 1 |
Equity pieces beside the debt: equity ($281,971 fair value, 1 BDC)
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A•••• C••••• B•• I••• | equity equity Investment T••• C•••• A U•••• A••••••••• D••• 3/21/2025 | Not disclosed | $281,971 118c | |
| A•••• C••••• B•• I••• | term loan first lien Investment T••• U••••••••• T••• L••• I•••• S+ S••••• 4.75% I••••••• R••• 8.48% A••••••••• | $3.6M | $3.6M 102c | SOFR+475 bp |
| A•••• C••••• B•• I••• | revolver first lien Investment T••• U••••••••• R••••••• I•••• S+ S••••• 4.75% I••••••• R••• 8.48% A••••••••• D | $69,088 | $69,088 114c | SOFR+475 bp |
| A•••• C••••• B•• I••• | revolver first lien Investment T••• S••••• S•••••• R•••••••• L••• I•••• S+ S••••• 4.75% I••••••• R••• 8.43% M• | Not disclosed | Not disclosed | SOFR+475 bp |
| A•••• C••••• B•• I••• | delayed draw term loan first lien Investment T••• S••••• S•••••• D•••••• D••• T••• L••• I•••• S+ S••••• 4.75% I••••••• R••• | Not disclosed | Not disclosed | SOFR+475 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $3.6M | $3.6M | 102c | 0 |
| Mar 31, 2026 | 1 | $3.3M | $3.3M | 102c | 0 |
| Dec 31, 2025 | 1 | $3.3M | $3.3M | 102c | 0 |
| Sep 30, 2025 | 2 | $3.3M | $3.3M | 102c | 0 |
| Jun 30, 2025 | 2 | $15.9M | $15.6M | 100c | 0 |
| Mar 31, 2025 | 1 | $29,609 | $29,091 | 139c | 0 |
| Dec 31, 2024 | 2 | $17.7M | $17.7M | 100c | 0 |
What changed
- Marked down (one lender)Jun 30, 2026
- Facility left every BDC scheduleSep 30, 2025
- Maturity extended (observed)Jun 30, 2025
- Lender left a facilityJun 30, 2025
- New lender joined a facilityJun 30, 2025
- Maturity extended (observed)Jun 30, 2025
- Facility left every BDC scheduleJun 30, 2025
- New borrower on a BDC scheduleDec 31, 2024
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- S••••• S••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 2 across 2 BDCsderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it